# TOFACITINIB
> **ANDA219395** · Abbreviated New Drug Application (Generic) · Sponsor: SPECGX LLC · Approved 2026-03-06
## Drug
- **FDA Application Number:** ANDA219395
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** TOFACITINIB
- **Generic name:** Tofacitinib Citrate
- **Active ingredients:** TOFACITINIB CITRATE
- **Dosage form:** TABLET
- **Route:** —
- **Marketing status:** None (Tentative Approval)
- **Sponsor:** SPECGX LLC
- **First approval:** 2026-03-06
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219395)
---
*AI Analytics · CC0 1.0*